Dr. Hanns-Martin Schmidt

Molecular Biologist | Biotech Founder | Scientific Visualization & Communication

Cologne Bonn Region

About

πŸš€ Advancing Biotech, Bridging Science & Application Passionate about transforming biotechnology and molecular biology into real-world applications across research, consulting, and science communication. With a PhD in Molecular Biology and extensive experience in R&D and biotech innovation, I work across different applied contexts where scientific depth meets practical implementation: 🧬 Biotech & Life Sciences – Deep insights & expertise in molecular biology. Founder of Ningaloo Biosystems. πŸ’‘ Scientific & Technical Consulting – Hands-on support for biotech projects and development challenges. πŸ“’ Science Communication & Media – Translating complex science into accessible narratives. Founder of Scinelion. πŸ“© Open to collaborations, freelance scientific consulting, and applied biotech projects.

Experience

  • CEO & Co-Founder at Ningaloo Biosystems GmbH
    Sep 2019 - Present Β· 6 yrs 10 mos

    Enabling Next-Gen Therapeutics Through Optogenetics

  • Owner at scinelion
    Jan 2009 - Present Β· 17 yrs 6 mos

    Creative Digital Media Production for HighTech Industries

  • Biotech Professional, Tech Consultant at HMSbioconsult
    Jun 2010 - Present Β· 16 yrs 1 mo

    Helping Life Science Startups Navigate Challenges & Scale

  • Senior Scientist/ Head of Analytics and QC at Celonic AG
    Oct 2006 - Jan 2008 Β· 1 yr 4 mos

    amongst others, developing and establishing HPLC methods in protein analytics; building up GMP-suited laboratories for analytics and quality control in Switzerland; approval of material for production under GMP-like conditions; qualification of lab devices, method validation;

  • Scientist/Senior Scientist at amaxa biosystems GmbH
    Sep 1999 - Jun 2006 Β· 6 yrs 10 mos

    mainly research & development as a part of product development; transfection technologies; cell culture; primary cells; establishing from the beginning the scientific department of one of GermanysΒ΄ most succesful biotech companies